{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:11:11Z","timestamp":1793419871770,"version":"4.5.0"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2024,4,16]]},"abstract":"Importance<\/jats:title>Finding a reliable diagnostic biomarker for the disorders collectively known as synucleinopathies (Parkinson disease [PD], dementia with Lewy bodies [DLB], multiple system atrophy [MSA], and pure autonomic failure [PAF]) is an urgent unmet need. Immunohistochemical detection of cutaneous phosphorylated \u03b1-synuclein may be a sensitive and specific clinical test for the diagnosis of synucleinopathies.<\/jats:p><\/jats:sec>Objective<\/jats:title>To evaluate the positivity rate of cutaneous \u03b1-synuclein deposition in patients with PD, DLB, MSA, and PAF.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This blinded, 30-site, cross-sectional study of academic and community-based neurology practices conducted from February 2021 through March 2023 included patients aged 40 to 99 years with a clinical diagnosis of PD, DLB, MSA, or PAF based on clinical consensus criteria and confirmed by an expert review panel and control participants aged 40 to 99 years with no history of examination findings or symptoms suggestive of a synucleinopathy or neurodegenerative disease. All participants completed detailed neurologic examinations and disease-specific questionnaires and underwent skin biopsy for detection of phosphorylated \u03b1-synuclein. An expert review panel blinded to pathologic data determined the final participant diagnosis.<\/jats:p><\/jats:sec>Exposure<\/jats:title>Skin biopsy for detection of phosphorylated \u03b1-synuclein.<\/jats:p><\/jats:sec>Main Outcomes<\/jats:title>Rates of detection of cutaneous \u03b1-synuclein in patients with PD, MSA, DLB, and PAF and controls without synucleinopathy.<\/jats:p><\/jats:sec>Results<\/jats:title>Of 428 enrolled participants, 343 were included in the primary analysis (mean [SD] age, 69.5 [9.1] years; 175 [51.0%] male); 223 met the consensus criteria for a synucleinopathy and 120 met criteria as controls after expert panel review. The proportions of individuals with cutaneous phosphorylated \u03b1-synuclein detected by skin biopsy were 92.7% (89 of 96) with PD, 98.2% (54 of 55) with MSA, 96.0% (48 of 50) with DLB, and 100% (22 of 22) with PAF; 3.3% (4 of 120) of controls had cutaneous phosphorylated \u03b1-synuclein detected.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this cross-sectional study, a high proportion of individuals meeting clinical consensus criteria for PD, DLB, MSA, and PAF had phosphorylated \u03b1-synuclein detected by skin biopsy. Further research is needed in unselected clinical populations to externally validate the findings and fully characterize the potential role of skin biopsy detection of phosphorylated \u03b1-synuclein in clinical care.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jama.2024.0792","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T15:01:25Z","timestamp":1710946885000},"page":"1298","source":"Crossref","is-referenced-by-count":210,"title":["Skin Biopsy Detection of Phosphorylated \u03b1-Synuclein in Patients With Synucleinopathies"],"prefix":"10.1001","volume":"331","author":[{"given":"Christopher H.","family":"Gibbons","sequence":"first","affiliation":[{"name":"Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Levine","sequence":"additional","affiliation":[{"name":"HonorHealth Neurology, Scottsdale, Arizona"},{"name":"CND Life Sciences, Scottsdale, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Adler","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic College of Medicine, Scottsdale, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bailey","family":"Bellaire","sequence":"additional","affiliation":[{"name":"CND Life Sciences, Scottsdale, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningshan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade","family":"Stohl","sequence":"additional","affiliation":[{"name":"CND Life Sciences, Scottsdale, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinky","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Evergreen Health, Kirkland, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina M.","family":"Aldridge","sequence":"additional","affiliation":[{"name":"Department of Neurology, Carver College of Medicine, University of Iowa, Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru","family":"Barboi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Northshore University Health System, Glenview, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virgilio G. H.","family":"Evidente","sequence":"additional","affiliation":[{"name":"Movement Disorder Center of Arizona, Scottsdale"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Galasko","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Geschwind","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of California, San Franscisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Gonzalez-Duarte","sequence":"additional","affiliation":[{"name":"Department of Neurology, New York University Grossman School of Medicine, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Gil","sequence":"additional","affiliation":[{"name":"Parkinson\u2019s Disease Treatment Center of Southwest Florida, Port Charlotte"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Gudesblatt","sequence":"additional","affiliation":[{"name":"Department of Neurology, New York University Grossman Long Island School of Medicine, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart H.","family":"Isaacson","sequence":"additional","affiliation":[{"name":"Parkinson\u2019s Disease and Movement Disorders Center of Boca Raton, Boca Raton, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horacio","family":"Kaufmann","sequence":"additional","affiliation":[{"name":"Department of Neurology, New York University Grossman School of Medicine, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravin","family":"Khemani","sequence":"additional","affiliation":[{"name":"Department of Neurology, Swedish Medical Center, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Kumar","sequence":"additional","affiliation":[{"name":"Rocky Mountain Movement Disorders Center, Englewood, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Lamotte","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy J.","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus R.","family":"McFarland","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Florida Health Center, Gainesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Miglis","sequence":"additional","affiliation":[{"name":"Department of Neurology, Stanford University Medical Center, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Center for Neurosciences, Tuscan, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Sahagian","sequence":"additional","affiliation":[{"name":"The Neurology Center of Southern California, Carlsbad"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Helene","family":"Saint-Hillaire","sequence":"additional","affiliation":[{"name":"Department of Neurology, Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie B.","family":"Schwartzbard","sequence":"additional","affiliation":[{"name":"Aventura Associates, Aventura, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Singer","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic Rochester, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Soileau","sequence":"additional","affiliation":[{"name":"Texas Movement Disorder Specialists, Georgetown"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Vernino","sequence":"additional","affiliation":[{"name":"Department of Neurology, The University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg","family":"Yerstein","sequence":"additional","affiliation":[{"name":"Department of Neurology, Lahey Clinic, Burlington, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Freeman","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"joi240011r1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41531-018-0058-0","article-title":"Prevalence of Parkinson\u2019s disease across North America.","volume":"4","author":"Marras","year":"2018","journal-title":"NPJ Parkinsons Dis"},{"issue":"7","key":"joi240011r2","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1001\/jamaneurol.2017.0603","article-title":"Survival and causes of death among people with clinically diagnosed synucleinopathies with parkinsonism: a population-based study.","volume":"74","author":"Savica","year":"2017","journal-title":"JAMA Neurol"},{"issue":"11","key":"joi240011r3","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1001\/jamaneurol.2013.3579","article-title":"Incidence of dementia with Lewy bodies and Parkinson disease dementia.","volume":"70","author":"Savica","year":"2013","journal-title":"JAMA Neurol"},{"issue":"7","key":"joi240011r4","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1001\/jamaneurol.2013.114","article-title":"Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism.","volume":"70","author":"Savica","year":"2013","journal-title":"JAMA Neurol"},{"issue":"2","key":"joi240011r5","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/ana.v81.2","article-title":"Natural history of pure autonomic failure: a United States prospective cohort.","volume":"81","author":"Kaufmann","year":"2017","journal-title":"Ann Neurol"},{"issue":"16","key":"joi240011r6","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1212\/WNL.0000000000002030","article-title":"Clinical implications of delayed orthostatic hypotension: a 10-year follow-up study.","volume":"85","author":"Gibbons","year":"2015","journal-title":"Neurology"},{"key":"joi240011r7","article-title":"Clinical diagnostic accuracy of early\/advanced Parkinson disease: updated clinicopathologic study.","author":"Adler","year":"2020","journal-title":"Neurol Clin Pract"},{"issue":"10","key":"joi240011r8","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/mds.v33.10","article-title":"Importance of low diagnostic accuracy for early Parkinson\u2019s disease.","volume":"33","author":"Beach","year":"2018","journal-title":"Mov Disord"},{"issue":"7","key":"joi240011r9","doi-asserted-by":"publisher","first-page":"499","DOI":"10.2217\/bmm-2021-0646","article-title":"Synuclein-One study: skin biopsy detection of phosphorylated a-synuclein for diagnosis of synucleinopathies.","volume":"16","author":"Gibbons","year":"2022","journal-title":"Biomark Med"},{"issue":"6","key":"joi240011r10","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1212\/WNL.42.6.1142","article-title":"What features improve the accuracy of clinical diagnosis in Parkinson\u2019s disease: a clinicopathologic study.","volume":"42","author":"Hughes","year":"1992","journal-title":"Neurology"},{"issue":"9","key":"joi240011r11","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy.","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"issue":"1","key":"joi240011r12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium.","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"issue":"1","key":"joi240011r13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurol.2009.09.001","article-title":"Movement Disorder Society-Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): a new scale for the evaluation of Parkinson\u2019s disease.","volume":"166","author":"Goetz","year":"2010","journal-title":"Rev Neurol (Paris)"},{"issue":"9","key":"joi240011r14","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/mds.v19:9","article-title":"Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations.","volume":"19","author":"Goetz","year":"2004","journal-title":"Mov Disord"},{"issue":"7","key":"joi240011r15","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/mds.v23:7","article-title":"The Montreal Cognitive Assessment as a screening tool for cognitive impairment in Parkinson\u2019s disease.","volume":"23","author":"Gill","year":"2008","journal-title":"Mov Disord"},{"issue":"5","key":"joi240011r16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3109\/07853890109002087","article-title":"EQ-5D: a measure of health status from the EuroQol Group.","volume":"33","author":"Rabin","year":"2001","journal-title":"Ann Med"},{"issue":"5","key":"joi240011r17","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/ageing\/26.5.353","article-title":"The Parkinson\u2019s Disease Questionnaire (PDQ-39): development and validation of a Parkinson\u2019s disease summary index score.","volume":"26","author":"Jenkinson","year":"1997","journal-title":"Age Ageing"},{"issue":"16","key":"joi240011r18","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1002\/mds.v22:16","article-title":"Measuring health-related quality of life in MSA: the MSA-QoL.","volume":"22","author":"Schrag","year":"2007","journal-title":"Mov Disord"},{"issue":"2","key":"joi240011r19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10286-011-0146-2","article-title":"The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale.","volume":"22","author":"Kaufmann","year":"2012","journal-title":"Clin Auton Res"},{"issue":"16","key":"joi240011r20","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1002\/mds.v22:16","article-title":"The REM sleep behavior disorder screening questionnaire\u2014a new diagnostic instrument.","volume":"22","author":"Stiasny-Kolster","year":"2007","journal-title":"Mov Disord"},{"issue":"15","key":"joi240011r21","doi-asserted-by":"publisher","first-page":"e1529","DOI":"10.1212\/WNL.0000000000206772","article-title":"Cutaneous a-synuclein signatures in patients with multiple system atrophy and Parkinson disease.","volume":"100","author":"Gibbons","year":"2023","journal-title":"Neurology"},{"issue":"10","key":"joi240011r22","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1369\/0022155420960250","article-title":"Phosphorylated alpha-synuclein within cutaneous autonomic nerves of patients with Parkinson\u2019s disease: the implications of sample thickness on results.","volume":"68","author":"Wang","year":"2020","journal-title":"J Histochem Cytochem"},{"issue":"2","key":"joi240011r23","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/ene.2016.23.issue-2","article-title":"A multi-center, multinational age- and gender-adjusted normative dataset for immunofluorescent intraepidermal nerve fiber density at the distal leg.","volume":"23","author":"Provitera","year":"2016","journal-title":"Eur J Neurol"},{"issue":"5","key":"joi240011r25","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1212\/WNL.0000000000001807","article-title":"When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients.","volume":"85","author":"Koga","year":"2015","journal-title":"Neurology"},{"issue":"Suppl 1","key":"joi240011r26","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.parkreldis.2017.07.033","article-title":"Neuropathology of Parkinson disease.","volume":"46","author":"Dickson","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"joi240011r27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2113489119","article-title":"Different a-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophy.","volume":"119","author":"Ayers","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"joi240011r28","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1093\/brain\/awac124","article-title":"Phosphorylated alpha-synuclein in skin Schwann cells: a new biomarker for multiple system atrophy.","volume":"146","author":"Donadio","year":"2023","journal-title":"Brain"},{"key":"joi240011r29","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105557","article-title":"Neuropathological evidence of body-first vs. brain-first Lewy body disease.","volume":"161","author":"Borghammer","year":"2021","journal-title":"Neurobiol Dis"},{"issue":"5","key":"joi240011r30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","article-title":"Assessment of heterogeneity among participants in the Parkinson\u2019s Progression Markers Initiative cohort using a-synuclein seed amplification: a cross-sectional study.","volume":"22","author":"Siderowf","year":"2023","journal-title":"Lancet Neurol"},{"issue":"1","key":"joi240011r31","first-page":"1","article-title":"Skin a-synuclein aggregation seeding activity as a novel biomarker for Parkinson disease.","volume":"78","author":"Wang","year":"2020","journal-title":"JAMA Neurol"},{"issue":"20","key":"joi240011r32","doi-asserted-by":"publisher","first-page":"e2513","DOI":"10.1212\/WNL.0000000000011935","article-title":"In vivo diagnosis of synucleinopathies: a comparative study of skin biopsy and RT-QuIC.","volume":"96","author":"Donadio","year":"2021","journal-title":"Neurology"},{"issue":"1","key":"joi240011r33","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41531-023-00473-5","article-title":"A comparative blind study between skin biopsy and seed amplification assay to disclose pathological a-synuclein in RBD.","volume":"9","author":"Liguori","year":"2023","journal-title":"NPJ Parkinsons Dis"},{"issue":"18","key":"joi240011r34","doi-asserted-by":"publisher","first-page":"e1944","DOI":"10.1212\/WNL.0000000000207147","article-title":"Misfolded a-synuclein assessment in the skin and CSF by RT-QuIC in isolated REM sleep behavior disorder.","volume":"100","author":"Iranzo","year":"2023","journal-title":"Neurology"},{"key":"joi240011r24","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198509844.001.0001","volume-title":"The Statistical Evaluation of Medical Tests for Classification and Prediction","author":"Pepe","year":"2003"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2816441\/jama_gibbons_2024_oi_240011_1712256174.7901.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T15:54:52Z","timestamp":1713282892000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2816441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,16]]},"references-count":34,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2024,4,16]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2024.0792","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,16]]}}}